Gabon researchers test promising single-dose malaria treatment

Doctors in Gabon say a new single-dose malaria treatment could help curb the disease’s growing resistance to existing drugs.

Led by Dr. Ghyslain Mombo-Ngoma at the Medical Research Centre of Lambaréné, researchers tested a one-time treatment combining four widely available anti-malarial compounds — sulfadoxine, pyrimethamine, artesunate, and pyronaridine. The new drug cleared malaria parasites in 93% of patients, matching the…